Related Experiment Videos

An experimental study of cefixime in the treatment of Streptococcus pneumoniae otitis media

A E Magit1, J N Dolitsky, W J Doyle

  • 1Department of Pediatric Otolaryngology, Children's Hospital of Pittsburgh, PA 15213-2583.

Insights

A single daily dose of cefixime effectively treats middle ear infections in chinchillas, matching split-dose cefixime and ampicillin. This supports daily cefixime for otitis media treatment.

Area of Science:

  • Otolaryngology
  • Infectious Diseases
  • Pharmacology

Background:

  • Otitis media is a common infection.
  • Strengths of third-generation cephalosporins like cefixime are well-established.
  • Previous research indicated split-dosing of cefixime efficacy.

Purpose of the Study:

  • To evaluate the efficacy of a single daily dose of cefixime compared to split dosing and ampicillin for treating otitis media.
  • To determine the time to sterilization of the middle ear cleft in an animal model.

Main Methods:

  • Investigator-blinded, randomized trial in a chinchilla model.
  • Comparison of single daily cefixime (8 mg/kg/day) versus split-dose cefixime (8 mg/kg every 8 hours) and ampicillin (150 mg/kg every 8 hours).
  • Inclusion of a saline control group.

Main Results:

  • Single daily cefixime demonstrated equivalent efficacy to split-dose cefixime and ampicillin in middle ear sterilization time.
  • No significant differences observed in otoscopy or tympanometry between antibiotic groups.
  • All antibiotic regimens were significantly more effective than saline control (P < 0.0001).

Conclusions:

  • Daily administration of cefixime is an effective treatment strategy for otitis media.
  • Cefixime's extended half-life and broad spectrum support its use in a once-daily regimen.
  • This study validates simplified dosing regimens for otitis media treatment.

Related Concept Videos